115 related articles for article (PubMed ID: 26286058)
21. Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size.
Gómez-González E; Caro C; García-Martín ML; Becerro AI; Ocaña M
Nanoscale; 2022 Aug; 14(31):11461-11470. PubMed ID: 35904370
[TBL] [Abstract][Full Text] [Related]
22. Ultrahigh-field 7-T magnetic resonance carotid vessel wall imaging: initial experience in comparison with 3-T field strength.
Kröner ES; van Schinkel LD; Versluis MJ; Brouwer NJ; van den Boogaard PJ; van der Wall EE; de Roos A; Webb AG; Siebelink HM; Lamb HJ
Invest Radiol; 2012 Dec; 47(12):697-704. PubMed ID: 22996317
[TBL] [Abstract][Full Text] [Related]
23. Size-Tailored Biocompatible FePt Nanoparticles for Dual
Slabu I; Wiemer K; Steitz J; Liffmann R; Mues B; Eisold S; Caumanns T; Mayer J; Kuhl CK; Schmitz-Rode T; Simon U
Langmuir; 2019 Aug; 35(32):10424-10434. PubMed ID: 31306025
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional layered gadolinium hydroxide nanoplates for ultrahigh field magnetic resonance imaging, computed tomography and fluorescence bioimaging.
Wu M; Li L; Yu X; Zhang D; Sun T; Li X; Sun L; Lui S; Huang X; Bi F; Wang H; Zhu H; Gong Q
J Biomed Nanotechnol; 2014 Dec; 10(12):3620-30. PubMed ID: 26000375
[TBL] [Abstract][Full Text] [Related]
25. Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging.
Harris M; Vander Elst L; Laurent S; Parac-Vogt TN
Dalton Trans; 2016 Mar; 45(11):4791-801. PubMed ID: 26865457
[TBL] [Abstract][Full Text] [Related]
26. The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.
Fries P; Morelli JN; Lux F; Tillement O; Schneider G; Buecker A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):559-73. PubMed ID: 25196203
[TBL] [Abstract][Full Text] [Related]
27. Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.
Rosenberg JT; Cisneros BT; Matson M; Sokoll M; Sachi-Kocher A; Bejarano FC; Wilson LJ; Grant SC
Contrast Media Mol Imaging; 2014; 9(1):92-9. PubMed ID: 24470298
[TBL] [Abstract][Full Text] [Related]
28. Molecular factors that determine Curie spin relaxation in dysprosium complexes.
Caravan P; Greenfield MT; Bulte JW
Magn Reson Med; 2001 Nov; 46(5):917-22. PubMed ID: 11675643
[TBL] [Abstract][Full Text] [Related]
29. Dysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging.
Debroye E; Laurent S; Vander Elst L; Muller RN; Parac-Vogt TN
Chemistry; 2013 Nov; 19(47):16019-28. PubMed ID: 24123216
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1- and T2-weighted MRI/CT/phosphorescence multimodality imaging.
Zhou J; Lu Z; Shan G; Wang S; Liao Y
Biomaterials; 2014 Jan; 35(1):368-77. PubMed ID: 24119502
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
32. Magnetic, biocompatible FeCO
Thangudu S; Yu CC; Lee CL; Liao MC; Su CH
J Nanobiotechnology; 2022 Mar; 20(1):157. PubMed ID: 35337331
[TBL] [Abstract][Full Text] [Related]
33. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Characterizations, and 9.4 Tesla T
Marasini S; Yue H; Ho SL; Park JA; Kim S; Jung KH; Cha H; Liu S; Tegafaw T; Ahmad MY; Ghazanfari A; Chae KS; Chang Y; Lee GH
Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34065511
[TBL] [Abstract][Full Text] [Related]
35. Promoting high
Ellis CM; Pellico J; Young LAJ; Miller J; Davis JJ
J Mater Chem B; 2022 Jan; 10(2):302-305. PubMed ID: 34914815
[TBL] [Abstract][Full Text] [Related]
36. Dysprosium-doped iron oxide nanoparticles boosting spin-spin relaxation: a computational and experimental study.
Yin J; Xu F; Qu H; Li C; Liu S; Liu L; Shao Y
Phys Chem Chem Phys; 2019 Jun; 21(22):11883-11891. PubMed ID: 31123740
[TBL] [Abstract][Full Text] [Related]
37. Determining the relaxivity values of protein cage-templated nanoparticles using magnetic resonance imaging.
Sana B; Lim S
Methods Mol Biol; 2015; 1252():39-50. PubMed ID: 25358771
[TBL] [Abstract][Full Text] [Related]
38. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI.
Van Roosbroeck R; Van Roy W; Stakenborg T; Trekker J; D'Hollander A; Dresselaers T; Himmelreich U; Lammertyn J; Lagae L
ACS Nano; 2014 Mar; 8(3):2269-78. PubMed ID: 24483137
[TBL] [Abstract][Full Text] [Related]
39. In vitro T2 relaxivities of the Gd-based contrast agents (GBCAs) in human blood at 1.5 and 3 T.
Shen Y; Goerner FL; Heverhagen JT; Snyder C; Hu D; Li X; Runge VM
Acta Radiol; 2019 Jun; 60(6):694-701. PubMed ID: 30205704
[TBL] [Abstract][Full Text] [Related]
40. Scaling Laws at the Nano Size: The Effect of Particle Size and Shape on the Magnetism and Relaxivity of Iron Oxide Nanoparticle Contrast Agents.
Smolensky ED; Park HY; Zhou Y; Rolla GA; Marjańska M; Botta M; Pierre VC
J Mater Chem B; 2013 Jun; 1(22):2818-2828. PubMed ID: 23819021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
